Helix BioPharma (TSE:HBP) Stock Passes Above 50-Day Moving Average - Here's What Happened

Key Points

• Helix BioPharma Corp. (TSE:HBP)'s stock price surpassed its 50-day moving average of C$1.13, reaching a high of C$1.45 during trading.
• The company's market capitalization is approximately C$110.75 million, with a price-to-earnings ratio of -1.41.
• Helix BioPharma is a clinical-stage biopharmaceutical company focused on cancer drug development, particularly in immuno-oncology therapies.

Helix BioPharma Corp. (TSE:HBP - Get Free Report)'s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$1.13 and traded as high as C$1.45. Helix BioPharma shares last traded at C$1.45, with a volume of 8,102 shares.

Helix BioPharma Stock Up 0.7%

The stock has a market cap of C$115.33 million, a price-to-earnings ratio of -1.47 and a beta of -0.45. The stock's fifty day moving average is C$1.17 and its 200-day moving average is C$0.98.

About Helix BioPharma

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.